About this trial
A major complication after cruciate ligament injury and surgery is arthrogenic muscle inhibition of the quadriceps, which is characterised by a deficit in voluntary muscle activation in the affected leg. This can hinder rehabilitation processes, lead to impaired knee function, and negatively impact the patients' quality of life. The primary objective of this study is to assess whether voluntary quadriceps activation on the injured side is facilitated by the concomitant application of neuromuscular electrical stimulation (NMES) on the contralateral quadriceps.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing ACL surgery with semitendinosus tendon autograft in the Schulthess Clinic
Unilateral and primary ACL injury (with/without diagnoses of additional meniscus injury)
Disqualifiers
Previous surgery/ligament rupture in injured or uninjured knee or hip
Severe pain in the uninjured-side quadriceps or knee joint
Ongoing pregnancy
BMI >30 kg/m²
Trial design
Single group
Treatments tested in this trial
Neuromuscular Electrical Stimulation
DeviceStudies in healthy individuals have demonstrated that NMES applied to the quadriceps of one limb induces short-term increases in strength and neural drive in the contralateral homologous muscle. Since these effects have only been observed in healthy individuals, it is essential to investigate whether similar responses occur in ACL patients.
Treatment groups
Trial outcomes
Primary outcomes
EMG activity
EMG data will be recorded from the vastus medialis, vastus lateralis and rectus femoris muscles.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: